ArriVent Biopharma

AVBP

全部股东

股东类型

  • 机构投资者66.80%
  • 对冲基金17.28%
  • 风投/私募13.43%
  • 个人与内部人士1.73%
  • 私营企业0.76%

主要股东

主要股东 最新
股东
Montanova Capital, LLC
9.16%451.55 万0.56%+11.44 万
Infinitum Asset Management, LLC
9.00%443.84 万0.16%+28.95 万
Hillhouse Investment Management, Ltd.
7.97%392.91 万0.70%+0
BlackRock, Inc.
6.59%325.04 万1.01%+72.01 万
OrbiMed Advisors LLC
6.14%302.73 万0.54%+0
FMR LLC
5.64%277.86 万1.02%-23.72 万
HBM Healthcare Investments AG
4.45%219.50 万0.39%+0
Eli Lilly Investment Consulting (Shanghai) Co., Ltd.
4.15%204.61 万0.37%+0
Vanguard Capital Management, LLC
4.13%203.42 万0.27%+28.81 万
Octagon Capital Advisors LP
4.00%197.11 万0.35%+0
Sofinnova Investments, Inc.
3.44%169.68 万0.30%+0
State Street Investment Management
3.43%169.30 万0.30%+27.16 万
Vivo Capital, LLC
3.41%168.21 万1.46%+79.62 万
Novo Holdings A/S
3.04%150.00 万1.24%-44.21 万
General Catalyst Group Management, LLC
3.03%149.48 万0.27%+0
Logos Global Management, L.P.
2.03%100.00 万1.26%+65.00 万
Geode Capital Management, LLC
1.97%97.26 万0.20%+16.90 万
D. E. Shaw & Co., L.P.
1.77%87.20 万0.95%+50.32 万
HongShan Capital Advisors Limited
1.35%66.33 万0.12%+0
Point72 Asset Management, L.P.
1.15%56.68 万0.50%-18.14 万